Advertisement

Pepleomycin, Interferon and Estracyt in the Treatment of Poorly Differentiated Prostatic Carcinoma

  • F. Edsmyr
  • L. Andersson
  • P. Esposti
  • P. O. Hedlund
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)

Abstract

An investigation using Pepleomycin in the treatment of prostatic carcinoma was reported at the WHO centre meeting on prostatic carcinoma in March 1979 in Stockholm (1). Some degree of objective and subjective improvement was observed in a series of six patients with stage C and D tumors. Side effects including gastro-intestinal disturbances, fever and dermatological symptoms were noted.

Keywords

Pain Relief Acid Phosphatase Prostatic Carcinoma Fine Needle Aspiration Biopsy Subjective Improvement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. Niijima and K. Koiso, Effect of Pepleomycin in Prostatic Carcinoma. A Preliminary Report. Scand. J. Urol. Nephrol.Suppl. 177 (1980).Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • F. Edsmyr
    • 1
  • L. Andersson
    • 1
  • P. Esposti
    • 1
  • P. O. Hedlund
    • 1
  1. 1.Karolinska InstituteStockholmSweden

Personalised recommendations